Simple and Efficient Recognition of Migraine With 3‐Question Headache Screen

Cady, Roger; Borchert, Leona D.; Spalding, William; Hart, Carolyn C.; Sheftell, Fred D.

doi:10.1111/j.1526-4610.2004.04075.x

Cited by 35 publications

(55 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The sensitivity and specificity values are quite similar to those of the German version [3]. Several other validated headache questionnaires exist, most of them constructed as screening instruments for migraine and consisting of 3-8 items based on the IHS criteria [11][12][13][14][15][16][17][18]. Lipton et al presented a very short screening questionnaire for migraine with only three items and were able to achieve a sensitivity of 0.81 and specificity of 0.75, with a kappa of 0.68 [14].…”

Section: Discussionmentioning

confidence: 59%

A pilot methodological validation study for a population-based survey of the prevalences of migraine, tension-type headache and chronic daily headache in the country of Georgia

et al. 2007

View full text Add to dashboard Cite

We report the methodology of an epidemiological survey of the prevalences of migraine, tension-type headache and chronic daily headache in Georgia. Medical residents visited adjacent households in Tbilisi to interview a pre-defined target of 100 biologically unrelated subjects. All respondents reporting headache in the previous year, as well as random 20 non-headache controls, were examined by a neurologist. The response rate was 70%. Of 156 respondents, 93 were biologically unrelated and 45 (48%) reported headache in the previous year. Eight subjects fulfilled all IHS criteria for migraine (1-year prevalence 8.6% [95% CI: 2.9-14.3%]), and 13 had probable migraine, meeting all but the criterion for duration. Nineteen had tension-type headache (20.4% [95% CI: 12.2-28.6%]) and five had chronic daily headache (5.4% [95% CI: 1-10.0%]). In comparisons of diagnoses by questionnaire and neurologist (considered the gold standard), sensitivities for the questionnaire of 89% for migraine and 67% for tension-type headache were calculated (overall kappa=0.74).

show abstract

Section: Discussionmentioning

confidence: 59%

A pilot methodological validation study for a population-based survey of the prevalences of migraine, tension-type headache and chronic daily headache in the country of Georgia

et al. 2007

View full text Add to dashboard Cite

show abstract

“…With this purpose and, in accordance to recommendations of experts on management of migraine [7,15,16], instruments for early detection have been developed in recent years, as the Diagnostic Headache Diary [17], the UCSD Migraine Questionnaire [18], the ID Migraine [19], the Brief Headache Screen [20], the 3-Question Headache Screen [21], and other [22-26], with the aim of assisting PC physicians to identify migraine patients in the shortest possible time, due to the important assistance load of health centers. This would not only improve the clinical approach to the diagnosis of migraine, but also contribute to improve patients' awareness of their disease, as often patients are not aware of this disorder and of its social, occupational, and clinical implications [27,28].…”

Section: Introductionmentioning

confidence: 99%

New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care

Láinez

Castillo²,

Domínguez

et al. 2010

BMC Neurol

View full text Add to dashboard Cite

BackgroundPC plays an important role in early diagnosis of health disorders, particularly migraine, due to the financial impact of this disease for the society and its impact on patients' quality of life. The aim of the study was to validate the self-administered MS-Q questionnaire for detection of hidden migraine in the field of primary care (PC), and to explore its use in this setting.MethodsCross-sectional, observational, and multicentre study in subjects above 18 years of age patients attending PC centers (regardless of the reason for consultation). A MS-Q score ≥ 4 was considered possible migraine. Level of agreement with IHS criteria clinical diagnosis (kappa coefficient), and instrument's validity properties: sensitivity, specificity, positive (PPV) and negative (NPV) predictive values were determined. The ability of the instrument to identify possible new cases of migraine was calculated, as well as the ratio of hidden disease compared to the ratio obtained by IHS criteria.ResultsA total of 9,670 patients were included [48.9 ± 17.2 years (mean ± SD); 61.9% women], from 410 PC centers representative of the whole national territory. The clinical prevalence of migraine according to the IHS criteria was 24.7%, and 20.4% according to MS-Q: Kappa index of agreement 0.82 (p < 0.05). MS-Q sensitivity was 0.82 (95% CI, 0.81 - 0.84), specificity 0.97 (95% CI, 0.98 - 0.99), PPV 0.95 (95% CI, 0.94 - 0.96), and NPV 0.94 (95% CI, 0.93 - 0.95). No statistically significant differences were found in the percentages of patients with de novo and hidden migraine identified by MS-Q and by IHS criteria: 5.7% vs. 6.1% and 26.6% vs. 24.1%, respectively.ConclusionsThe results of the present study confirm the usefulness of the MS-Q questionnaire for the early detection and assessment of migraine in PC settings, and its ability to detect hidden migraine.

show abstract

“…Despite advances in the understanding of migraine pathophysiology [1,2,3], the creation of short and simple diagnostic questionnaires [4, 5], and the development of triptans for specific acute therapy [6], migraine continues to be inadequately treated. For example, the FRAMIG 2000 study, a population-based survey of migraine diagnosis and treatment patterns in France, found that nearly one fourth of migraineurs had never consulted a physician regarding their migraines, 82% had no medical follow-up for migraine, and 59% of migraineurs who had previously seen a doctor for migraine had lapsed consulting [7].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Efficacy, Tolerability, and Treatment Satisfaction with Almotriptan in 3 Consecutive Migraine Attacks

Massiou

Pradalier²,

Donnet³

et al. 2006

Eur Neurol

View full text Add to dashboard Cite

The objective of the open-label, multicenter Migraine – Satisfaction with Treatment: Reality with Almogran® study was to assess efficacy, tolerability, and satisfaction with almotriptan 12.5 mg among migraineurs who were not achieving adequate results with their current acute therapy. Data from 434 patients (342 evaluable), were obtained for 929 attacks by 154 neurologists in France. Using a questionnaire developed by the National Agency for Accreditation and Evaluation in Health (ANAES), almotriptan was associated with an increased proportion of patients experiencing significant relief at 2 h (69.3 vs. 26.6%), tolerating the medication well (91.2 vs. 76.0%), able to resume activities (70.5 vs. 24.9%), and taking only 1 dose (59.4 vs. 28.1%) compared with previous therapies. At 2 h, headache pain had disappeared in 33.4% of attacks and was mild in 26.9%. Recurrence rate was 28.4% and rescue analgesics were used in 20.9% of attacks. The rate of adverse event-related discontinuations was 2.6%. The proportion of patients who were very satisfied/satisfied overall with almotriptan treatment was 69%. Almotriptan 12.5 mg was effective, well-tolerated and associated with a high rate of treatment satisfaction in patients whose previous acute migraine therapy was inadequate according to the ANAES recommendations.

show abstract

Simple and Efficient Recognition of Migraine With 3‐Question Headache Screen

Abstract: Positive 3-question headache screen results agreed well with migraine diagnoses based on International Headache Society criteria, clinical impressions, and presence of recurring disabling headaches. These findings support use of the 3-question headache screen to recognize migraine.

Cited by 35 publications

References 15 publications

A pilot methodological validation study for a population-based survey of the prevalences of migraine, tension-type headache and chronic daily headache in the country of Georgia

A pilot methodological validation study for a population-based survey of the prevalences of migraine, tension-type headache and chronic daily headache in the country of Georgia

New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care

Evaluation of Efficacy, Tolerability, and Treatment Satisfaction with Almotriptan in 3 Consecutive Migraine Attacks

Contact Info

Product

Resources

About